Otcmkts axim.

Director, AXIM BioTech (AXIM). ▫ President US Operations & Director ... Chung maintains several Board Appointments including Cure Pharmaceutical Holding Corp. ( ...Post Views: 293 AXIM Biotechnologies Inc. (OTCMKTS: AXIM) has announced a partnership with Arizona State University (ASU)for the development of a COVID-19 “Correlate of protection” through the company’s rapid neutralizing antibody test. AXIM and ASU collaborate to create a “Correlate of Protection” for COVID-19 The company and ASU will collaborate to meet this unmet need […]Post Views: 1,468 Medical Marijuana (OTCMKTS:MJNA) has announced that Kannalife Inc. (OTCMKTS:KLFE) its investment company has received a Notice of Allowance for the "Atopidine" trademark application from the US Patent and Trademark Office. Kannalife picks trademark for the KLS-13022 compound The investment company picked the trademark AtopidineTM for Limonenyldihydroxybenzyl ...Get the latest Axim Biotechnologies Inc (AXIM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Post Views: 565 Axim Biotechnologies Inc (OTCMKTS:AXIM) reported that it has filed with the USPTO a patent of invention that comprises a chewing gum composition having controlled release of opioid and cannabinoids and/or antagonists for dependence treatment and/or addiction. The chewing gum may work as a means for treatment of chronic pain. The details George […]

Aldel Financial Inc. OTCMKTS. ADF-WS, ADF-WS, NYSE. ADFAX, American Century Diversified Bond Fund, NMFQS. ADFI, Anfield Dynamic ...StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH - Get Free Report) in a report issued on Thursday. The brokerage set a "hold" rating on the biotechnology company's stock. A number of other research analysts have also recently commented on BLPH. HC Wainwright reduced their price objective on Bellerophon Therapeutics from $30.00 to $2.00 […]

Jan 3, 2022 · Following were the most active stock buzzers on Friday. Keep an eye on these stocks this week. Abraxas Petroleum Corporation (OTCMKTS:AXAS) stock continued t To je brz i konkurentan svijet! Neki ljude ostavljaju za sobom, dok vrijeme ostavlja sve iza sebe. Uvijek biste trebali pokušati držati korak s tim( OTCQB: AXIM ) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that it has begun shipping revenue generating validation kits of one of its ophthalmological diagnostic assays. The proprietary assay is designed for the diagnosis of dry eye disease …AXIM Biotechnologies (OTCMKTS:AXIM - Get Rating) is one of 356 publicly-traded companies in the "Biotechnology" industry, but how does it weigh in compared to its peers?Axim Biotechnologies Inc (OTCMKTS:AXIM) shares have been ramping higher in an aggressive bounce over recent days. Technically, the move comes following a firm hold of support just under the $4/share level, with volume ramping significantly in the last two days, as the stock broke back above its falling 50-day simple moving average. However, in this case, […]

Gladstone Commercial Co. (NASDAQ:GOODO - Get Rating) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling ...

Feb 21, 2022 · Post Views: 617 Obtaining adequate samples for tear analysis is a tall order, which requires an effective collection method. The standard method is the use of capillary designs, which, more often than not, are intimidating, expensive to manufacture and difficult to use by untrained people. However, AXIM Biotechnologies (OTCMKTS: AXIM) has come forth to change […]

Axim Biotechnology Inc. (OTCMKTS:AXIM) has announced that its manufacturing partner Empowered Diagnostics has filed an Emergency Use Authorization (EUA) application with US FDA for ImmunoPass™'s approval. ImmunoPass™ is the company's rapid test kit that measures COVID-19 neutralizing antibody levels to detect neutralizing antibodies in whole blood.Folger Nolan Fleming Douglas Capital Management Inc. lessened its stake in PepsiCo, Inc. (NASDAQ:PEP - Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 94,084 shares of the company's stock after selling 1,313 shares during the quarter. PepsiCo comprises […]Jushi Holdings Inc (OTCMKTS: JUSHF) Closes An Aggregate of 1,000,000 Subordinate Voting Shares With Kenneth Rosen and Group. BUSINESS 1 year ago. Harvest One Cannabis Inc (OTCMKTS: HRVOF) Launches LivRelief Infused Extra Strength Transdermal CBD Cream.NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced the company’s Chief Technology Officer Lekhram Changoer will be speaking at the “Believe” National Convention held by Kannaway ®, the …Folger Nolan Fleming Douglas Capital Management Inc. lessened its stake in PepsiCo, Inc. (NASDAQ:PEP - Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 94,084 shares of the company's stock after selling 1,313 shares during the quarter. PepsiCo comprises […]

AXIM Biotechnologies ( OTCQB:AXIM ) announces that it has developed a rapid 10-minute point-of-care blood test for COVID-19 antibodies, branded as NeuCovix, that, it says, measures a specific...SAN DIEGO, July 15, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovix TM, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from ...( OTCQB: AXIM ) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that it has begun shipping revenue generating validation kits of one of its ophthalmological diagnostic assays. The proprietary assay is designed for the diagnosis of dry eye disease …AXIM looks like a great short into calendar year-end and a buy for a January effect recovery at the beginning of January 2017, after any "bag holders" have dumped for tax loss selling. Will have ...Post Views: 293 AXIM Biotechnologies Inc. (OTCMKTS: AXIM) has announced a partnership with Arizona State University (ASU)for the development of a COVID-19 “Correlate of protection” through the company’s rapid neutralizing antibody test. AXIM and ASU collaborate to create a “Correlate of Protection” for COVID-19 The company and ASU will collaborate to meet this unmet need […]Post Views: 724 AXIM Biotechnologies Inc (OTCMKTS: AXIM) has announced the hiring of Joseph Tauber as the Chairman of the Medical Advisory Board and its chief medical officer. Dr. Tauber has vast experience as an ophthalmologist Dr Taube, an ophthalmologist, is recognized internationally as an expert on ocular surface diseases like meibomitis and dry eye.May 24, 2023 · ( OTCQB: AXIM ) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that through its distribution partner Verseá Ophthalmics it has received commitments from over 40 clinics across the United States for implementation of both of its FDA-cleared Dry Eye ...

Leading Dry Eye Disease Diagnostic Healthcare Company’s Assays to be Performed in Over 40 Initial Clinics Across US . SAN DIEGO, CA, May 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions …Axim Biotechnologies (OTCMKTS:AXIM) makes a really cool product.It is a biotechnology company based in New York City. The company makes chewing gum that is infused with medicinal cannabis.This is ...

Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community. Torah Network (VP) traded down 11.8% against the dollar during the one day period ending at 7:00 AM ET on July 18th. One Torah Network token can now be bought for $0.80 or 0.00002672 BTC on popular cryptocurrency exchanges. In the last week, Torah Network has traded down 32.8% against the dollar. Torah Network has […]OTCMKTS:AXIM AXIM Biotechnologies (AXIM) News Today $0.03 0.00 (0.00%) (As of 09/15/2023 ET) Compare Today's Range $0.02 $0.03 50-Day Range $0.02 $0.03 52-Week Range $0.02 $0.12 Volume 447,916 shs Average Volume 375,957 shs Market Capitalization N/A P/E Ratio N/A Dividend Yield N/A Price Target N/ASAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics and oncological research, announced today that it has partnered with Arizona State University to develop a COVID-19 “Correlate of …Products that AXIM could produce under this patent will be made using cannabinoids. The patented formula maximizes the presence of CBD in the oral cavity during brushing. Additionally, all formulations through this patent will include CBD, which contains fast-acting anti-bacterial properties. AXIM hopes to utilize this patent in development of ...இது வேகமான மற்றும் போட்டி நிறைந்த உலகம்! சிலர் மற்றவர்களை ...

OTCMKTS:AXIM AXIM Biotechnologies (AXIM) News Today $0.03 0.00 (0.00%) (As of 09/15/2023 ET) Compare Today's Range $0.02 $0.03 50-Day Range $0.02 $0.03 52-Week Range $0.02 $0.12 Volume 447,916 shs Average Volume 375,957 shs Market Capitalization N/A P/E Ratio N/A Dividend Yield N/A Price Target N/A

ATLANTA, Aug. 12, 2019 /PRNewswire/ — PRESS RELEASE — Surterra Wellness, one of the fastest growing health and wellness companies in the United States, has announced the expansion of its leadership team with the appointment of Stevens J. Sainte-Rose as Chief Human Resources Officer (CHRO) and as a member of its Executive Leadership Team.In this role, Sainte-Rose will lead Surterra's ...

Post Views: 617 Obtaining adequate samples for tear analysis is a tall order, which requires an effective collection method. The standard method is the use of capillary designs, which, more often than not, are intimidating, expensive to manufacture and difficult to use by untrained people. However, AXIM Biotechnologies (OTCMKTS: AXIM) has …AXIM, Axim Biotechnologies Inc, 0.0234, 0.0184, 0.0194, 754,568, -0.0016, 7.62. AXLX, Axiologix Inc, 0.0001, 0.0001, 0.0001, 500, 0.0000, 0.00. AXMIF, Axmin Inc ...Boxlight (NASDAQ:BOXL - Get Free Report) had its target price cut by investment analysts at Alliance Global Partners from $14.00 to $9.00 in a research report issued on Thursday, MarketBeat.com reports. The firm presently has a "buy" rating on the stock. Alliance Global Partners' target price would suggest a potential upside of 312.84% from the […]AXIM Biotechnologies, Inc . ( OTCQB: AXIM ) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today the receipt of notification by the United States Patent & Trademark Office of …Axim Biotechnologies Inc (OTCMKTS:AXIM) has been a moon shot since the presidential election rallying from .40 cents to $19.00. These unprecedented moves happening in the cannabis sector come with extreme volatility. Stocks never go straight up, and AXIM shares have had the expected pullback, with a recent retest of the $8.00 this month. Look below and […]Бул тез жана атаандаштыкка жөндөмдүү дүйнө! Кээ бир адамдар башкаларды артта калтырышса, убакыт ар кимди артка таштап жатат. Сиз ар дайым аракет кылып, аны менен жүрүшүңүз керекPfizer (NYSE:PFE) has been given a $36.00 price objective by analysts at Berenberg Bank in a research note issued on Tuesday. The brokerage presently has a "neutral" rating on the biopharmaceutical company's stock. Berenberg Bank's price objective suggests a potential downside of 4.66% from the company's previous close. A number of other brokerages also recently […]Baker Tilly Wealth Management LLC decreased its position in shares of Aon plc (NYSE:AON - Get Rating) by 2.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,504 shares of the financial services provider's stock after selling 41 shares during the quarter. Baker Tilly Wealth Management LLC's holdings in AON were worth $403,000 […]Medical Marijuana, Inc. (OTCMKTS:MJNA) has announced that subsidiary Kannaway® has placed a substantial purchase order from AXIM Biotechnologies (OTCMKTS:AXIM) for its CBD nutraceutical chewing gum. Kannaway® creating a nutraceutical brand Kannaway is a lifestyle network offering CBD hemp products. Blake …AXIM Biotechnologies Inc (OTC:AXIM), which has a market cap of US$17mln, has started human clinical trials for its ointment AX-1602 for psoriasis and... This website uses cookies. We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of …

Axim Biotechnologies Inc (OTCMKTS:AXIM) has been soaring higher in recent sessions, on news that the company has secured private funding to continue its pharmaceutical clinical trials program in cannabinoid research and development for multiple indications. In all, we've seen over 350% in two days as news of the successful financing works its way through the ravenous […]SAN DIEGO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a leader in the development of diagnostic testing for COVID-19, dry eye disease (DED) and Cancer, today announced that it has appointed Jeffrey A. Busby to Senior Vice President – business Development. …Post Views: 222 Dry Eye Disease (DED) impacts increase with age and can significantly impair quality of life and visual acuity. The condition occurs when a person’s tears are not able to provide adequate lubrication for the eyes. Studies indicate that more than 20 million people suffer from Dry Eye Disease, whose symptoms are still […]Instagram:https://instagram. nyc five boro bike tour road closurescannibal parlierhoboshoestringgreen bay wisconsin press gazette obituaries NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today its oncology-focused subsidiary, Sapphire Biotech, Inc. (“Sapphire”), filed a utility patent application … dennard first national funeral homeffxiv which cloth is most to your liking ( OTCQB: AXIM ) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today that it has begun shipping revenue generating validation kits of one of its ophthalmological diagnostic assays. The proprietary assay is designed for the diagnosis of dry eye disease (DED ...Get the latest Axim Biotechnologies Inc (AXIM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. planet fitness martin luther king Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community. OTCMKTS: AXIM Biotechnology VISIT WEBSITE Diagnostic Healthcare Solutions Company Developing New Test Designed to Measure Neutralizing Antibodies of Deadly Opioid Fentanyl. SAN DIEGO, CA, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via ...